SYNTASE
LIVE

Serial Number

99421485

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Sep 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SYNTASE Trademark

Serial Number: 99421485

SYNTASE is a trademark filed by CRISPR Therapeutics AG on September 30, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

September 30, 2025

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy; Research in the field of gene editing technology; Providing a gene editing platform for others to conduct pharmaceutical research and development in the field of in vivo gene editing therapy

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2026 CNSA
ASSIGNED TO EXAMINER
Feb 19, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 30, 2025 MAFR
NEW APPLICATION ENTERED
Sep 30, 2025 NWAP